FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2854223583> ?p ?o ?g. }

• W2854223583 endingPage "514" @default.
• W2854223583 startingPage "507" @default.
• W2854223583 abstract "The body mass index (BMI) may be associated with an increased incidence and aggressiveness of urological cancers. In this study, we aimed to evaluate the impact of the BMI on survival in patients with T1G3 non-muscle-invasive bladder cancer (NMIBC). A total of 1155 T1G3 NMIBC patients from 13 academic institutions were retrospectively reviewed and patients administered adjuvant intravesical Bacillus Calmette–Guérin (BCG) immunotherapy with maintenance were included. Multivariable Cox regression analysis was performed to identify factors predictive of recurrence and progression. After re-TURBT, 288 patients (27.53%) showed residual high-grade NMIBC, while 867 (82.89%) were negative. During follow-up, 678 (64.82%) suffered recurrence, and 303 (30%) progression, 150 (14.34%) died of all causes, and 77 (7.36%) died of bladder cancer. At multivariate analysis, tumor size (hazard ratio [HR]:1.3; p = 0.001), and multifocality (HR:1.24; p = 0.004) were significantly associated with recurrence (c-index for the model:55.98). Overweight (HR: 4; p < 0.001) and obesity (HR:5.33 p < 0.001) were significantly associated with an increased risk of recurrence. Addition of the BMI to a model that included standard clinicopathological factors increased the C-index by 9.9. For progression, we found that tumor size (HR:1.63; p < 0.001), multifocality (HR:1.31; p = 0.01) and concomitant CIS (HR: 2.07; p < 0.001) were significant prognostic factors at multivariate analysis (C-index 63.8). Overweight (HR: 2.52; p < 0.001) and obesity (HR: 2.521 p < 0.001) were significantly associated with an increased risk of progression. Addition of the BMI to a model that included standard clinicopathological factors increased the C-index by 1.9. The BMI could have a relevant role in the clinical management of T1G3 NMIBC, if associated with bladder cancer recurrence and progression. In particular, this anthropometric factor should be taken into account at initial diagnosis and in therapeutic strategy decision making." @default.
• W2854223583 created "2018-07-19" @default.
• W2854223583 creator A5001805404 @default.
• W2854223583 creator A5003038893 @default.
• W2854223583 creator A5003926333 @default.
• W2854223583 creator A5003929233 @default.
• W2854223583 creator A5009887316 @default.
• W2854223583 creator A5013771798 @default.
• W2854223583 creator A5014614796 @default.
• W2854223583 creator A5017259461 @default.
• W2854223583 creator A5024587083 @default.
• W2854223583 creator A5025279590 @default.
• W2854223583 creator A5027115920 @default.
• W2854223583 creator A5029088271 @default.
• W2854223583 creator A5031961999 @default.
• W2854223583 creator A5039787408 @default.
• W2854223583 creator A5042911985 @default.
• W2854223583 creator A5042997171 @default.
• W2854223583 creator A5044720061 @default.
• W2854223583 creator A5046567234 @default.
• W2854223583 creator A5048032405 @default.
• W2854223583 creator A5048712745 @default.
• W2854223583 creator A5050834286 @default.
• W2854223583 creator A5057582336 @default.
• W2854223583 creator A5057612328 @default.
• W2854223583 creator A5059271730 @default.
• W2854223583 creator A5059553692 @default.
• W2854223583 creator A5060543983 @default.
• W2854223583 creator A5067807364 @default.
• W2854223583 creator A5068357554 @default.
• W2854223583 creator A5069476166 @default.
• W2854223583 creator A5070965901 @default.
• W2854223583 creator A5078389550 @default.
• W2854223583 creator A5079571836 @default.
• W2854223583 creator A5079980788 @default.
• W2854223583 creator A5084401223 @default.
• W2854223583 creator A5086324393 @default.
• W2854223583 date "2018-07-10" @default.
• W2854223583 modified "2023-10-18" @default.
• W2854223583 title "An increased body mass index is associated with a worse prognosis in patients administered BCG immunotherapy for T1 bladder cancer" @default.
• W2854223583 cites W1482328974 @default.
• W2854223583 cites W1491838516 @default.
• W2854223583 cites W1533650394 @default.
• W2854223583 cites W1778688357 @default.
• W2854223583 cites W1973611057 @default.
• W2854223583 cites W1990436525 @default.
• W2854223583 cites W2007682549 @default.
• W2854223583 cites W2009979998 @default.
• W2854223583 cites W2010644263 @default.
• W2854223583 cites W2046859247 @default.
• W2854223583 cites W2064352891 @default.
• W2854223583 cites W2070511997 @default.
• W2854223583 cites W2120386078 @default.
• W2854223583 cites W2120854891 @default.
• W2854223583 cites W2141662760 @default.
• W2854223583 cites W2142296587 @default.
• W2854223583 cites W2163710303 @default.
• W2854223583 cites W2270022169 @default.
• W2854223583 cites W2603836673 @default.
• W2854223583 cites W2765268081 @default.
• W2854223583 cites W2765421232 @default.
• W2854223583 cites W2783634162 @default.
• W2854223583 cites W2809403838 @default.
• W2854223583 cites W2916183155 @default.
• W2854223583 cites W361109285 @default.
• W2854223583 doi "https://doi.org/10.1007/s00345-018-2397-1" @default.
• W2854223583 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29992381" @default.
• W2854223583 hasPublicationYear "2018" @default.
• W2854223583 type Work @default.
• W2854223583 sameAs 2854223583 @default.
• W2854223583 citedByCount "74" @default.
• W2854223583 countsByYear W28542235832018 @default.
• W2854223583 countsByYear W28542235832019 @default.
• W2854223583 countsByYear W28542235832020 @default.
• W2854223583 countsByYear W28542235832021 @default.
• W2854223583 countsByYear W28542235832022 @default.
• W2854223583 countsByYear W28542235832023 @default.
• W2854223583 crossrefType "journal-article" @default.
• W2854223583 hasAuthorship W2854223583A5001805404 @default.
• W2854223583 hasAuthorship W2854223583A5003038893 @default.
• W2854223583 hasAuthorship W2854223583A5003926333 @default.
• W2854223583 hasAuthorship W2854223583A5003929233 @default.
• W2854223583 hasAuthorship W2854223583A5009887316 @default.
• W2854223583 hasAuthorship W2854223583A5013771798 @default.
• W2854223583 hasAuthorship W2854223583A5014614796 @default.
• W2854223583 hasAuthorship W2854223583A5017259461 @default.
• W2854223583 hasAuthorship W2854223583A5024587083 @default.
• W2854223583 hasAuthorship W2854223583A5025279590 @default.
• W2854223583 hasAuthorship W2854223583A5027115920 @default.
• W2854223583 hasAuthorship W2854223583A5029088271 @default.
• W2854223583 hasAuthorship W2854223583A5031961999 @default.
• W2854223583 hasAuthorship W2854223583A5039787408 @default.
• W2854223583 hasAuthorship W2854223583A5042911985 @default.
• W2854223583 hasAuthorship W2854223583A5042997171 @default.
• W2854223583 hasAuthorship W2854223583A5044720061 @default.
• W2854223583 hasAuthorship W2854223583A5046567234 @default.
• W2854223583 hasAuthorship W2854223583A5048032405 @default.
• W2854223583 hasAuthorship W2854223583A5048712745 @default.

• next